2021 annual financial data
Sarepta Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -443,172,000 USD.
Operating income was -459,710,000 USD and net income was -418,780,000 USD.
Operating cash flow was -443,172,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 701,887,000 USD
- Operating income
- -459,710,000 USD
- Net income
- -418,780,000 USD
- Operating cash flow
- -443,172,000 USD